Drugs / Seretide Diskus
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 1 | NCT01856621 Comparator | May → Sep 2013 | asthma | Orion Corporation, Orion Pharma | Completed | No outcome recorded |
| Phase 1 | NCT01521455 Comparator | Feb 2012 → Jun 2013 | asthma | Hanmi Pharmaceutical Company Limited | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Seretide Diskus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01856621 ↗ |
| Route | Inhaled | “2 inhalations as a single dose” NCT01856621 ↗ |